Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEN-004 vaccine challenge study in healthy adults
2014-000944-13Phase 2Completed
- Sponsor
- Genocea Biosciences
- Start
- Jun 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pneumococcal disease comparing GEN-004 with aluminum hydroxide with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jun 2014; status: completed.
02
Drugs
GEN-004
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2014-000944-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000944-13.